£1k to invest? 2 UK shares I’d buy in an ISA today

These UK shares could produce large total returns for investors in the years ahead as growth tailwinds help drive earnings.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you have a lump sum of £1,000, or any other amount to invest, I think it could be sensible to buy UK shares in an ISA. With that in mind, here are two companies I’ve got my eye on today. 

UK shares to buy

Hikma Pharmaceuticals (LSE: HIK) has been one of the best-performing stocks on the London market this year. Investor sentiment towards the pharmaceutical group has improved because it supplies several of the drugs required to treat coronavirus

Thanks for the growing demand for these drugs, City analysts are expecting the company to report earnings per share for the year of $1.70. That’s up from $1.50 at the beginning of the year. 

There are other reasons why I think Hikma could be one of the best UK shares to buy today. The demand for healthcare around the world is only growing, and the company is one of the largest producers of low-cost generic treatments.

For emerging and developing economies, these low-cost products are vital. As such, Hikma has a very defensive nature and is likely to continue to produce steady returns for investors for many decades to come. 

Over the past five-years, Hikma’s bottom line has doubled, thanks to the growing demand for pharmaceutical products around the world. The company’s own research and development efforts have helped improve growth. With profits surging, Hikma has become a dividend champion. Its payout has grown at a compound annual rate of 17% since 2014. Today, the stock supports a dividend yield of 1.5%.

In my opinion, this income potential, as well as the company’s long-term growth outlook, is highly exciting. These qualities are relatively unique among UK shares. 

Rentokil Initial

Pest control business Rentokil Initial (LSE: RTO) has achieved a similar rate of growth to Hikma over the past five years. The company’s long-term outlook is also extremely attractive.

The company is potentially one of the best-known pest control businesses in the UK. Demand for its services is only growing. Scientists believe climate change is contributing to rising pest levels. That’s terrible news for the planet, but potentially good news for pest control businesses.

On top of this organic growth, Rentokil has a strong track record of buying up smaller competitors and integrating them into the wider business. As the company grows, it looks as if this trend will continue. The pest control market is large but highly fragmented. Rentokil is one of the few businesses that has the size and skill to acquire smaller competitors

As such, I think it may be worth acquiring the stock as part of an ISA portfolio of UK shares. The company has significant growth potential in the years ahead, which could lead to large total returns for investors. Even if the stock does look expensive at current levels, I think it’s a price worth paying to buy this UK growth champion.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 26%, can the BT share price really push higher still?

The BT share price has surged on several catalysts in 2024, but there’s evidence to suggest that the stock could…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

What are the best dividend shares to buy right now?

As shares in B&M European Value Retail have fallen, the dividend yield has reached a 10-year high. Should investors be…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

My favourite FTSE 100 passive income stock that keeps the Christmas coffers full

The holiday season is expensive and can leave many consumers struggling to make ends meet. Here’s how I use a…

Read more »

Investing Articles

The latest growth forecasts suggest the Glencore share price will hit 555p!

Harvey Jones has been disappointed by the performance of the Glencore share price since he bought the commodity stock last…

Read more »

Dividend Shares

A closer look at the 11% dividend yield forecast for Phoenix Group shares

Phoenix Group shares have one of the highest dividend yields in the FTSE 100 index today. Could this be a…

Read more »

Investing Articles

If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for…

Read more »

Investing Articles

Up 40%, but experts forecast the easyJet share price could soon hit 664p! Time to buy?

The easyJet share price has been flying lately and stock analysts are predicting more fun to come. But there's only…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

Worried about tax raids? Here’s how I’m targeting a £44,526 passive income with shares

Investing in a Self-Invested Personal Pension (SIPP) or Individual Savings Account (ISA) can supercharge one's passive income, says Royston Wild.

Read more »